Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Aug 2026 for KLAVIYO, INC, €32k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Summit Investors GE IX/VC IV (UK), L.P.: trading record in brief
Summit Investors GE IX/VC IV (UK), L.P. discloses dealings in 2 companies, chiefly Klaviyo, Inc. and LifeStance Health Group, Inc. Over a trading history stretching from 10 August 2026 to 11 August 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 11 August 2026 came the latest disclosure, a transaction for €32k in Klaviyo, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Summit Investors GE IX/VC IV (UK), L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,016 shares@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001846709-26-000005
1,273 shares@ US$10.620.0003% mcap100.0% of flowCommon StockSEC144:0001846709-26-000003
2 of 2 declarations
